In contrast, CLL13 xenografts treated with ibrutinib showed a trend towards selection for the cytogenetically more complex subpopulation carrying trisomy 12 in combination with del(6q) and del(11q).
← all excerpts
Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts.
1
—
—